Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Xencor, Inc.

XNCR Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of XNCR by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
XNCR Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
XNCR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
XNCR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in XNCR holdings by institutional investors

Quarterly net insider trading by XNCR's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for XNCR

Quiver Logo

No former government officials on record as having lobbied for XNCR

Revolving Door Dashboard

XNCR Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

XNCR Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
XNCR Income Statement
XNCR Balance Sheet
XNCR Cash Flow
U.S. Patents

New XNCR patent grants

  • Patent Title: Methods and compositions for inhibiting cd32b expressing cells Mar. 13, 2018
  • Patent Title: Methods and compositions for inhibiting cd32b expressing cells Feb. 27, 2018
  • Patent Title: Heterodimeric antibodies to cd3 x cd123 Jan. 02, 2018
  • Patent Title: Heterodimeric antibodies to cd3 x cd20 Dec. 26, 2017
  • Patent Title: Bispecific antibodies that bind to cd38 and cd3 Nov. 21, 2017
  • Patent Title: Fc variants with altered binding to fcrn Oct. 31, 2017
  • Patent Title: Optimized antibodies that target cd19 Oct. 31, 2017
  • Patent Title: Rapid clearance of antigen complexes using novel antibodies Aug. 22, 2017
  • Patent Title: Optimized fc variants and methods for their generation Jul. 25, 2017
  • Patent Title: Heterodimeric proteins Jul. 11, 2017
  • Patent Title: Optimized fc variants May. 30, 2017
  • Patent Title: Optimized fc variants May. 23, 2017
  • Patent Title: Heterodimeric proteins May. 16, 2017
  • Patent Title: Compositions and methods for treating ige-mediated disorders Apr. 11, 2017
  • Patent Title: Heterodimeric proteins Mar. 28, 2017
  • Patent Title: Antibodies with modified isoelectric points Mar. 28, 2017
  • Patent Title: Optimized anti-cd30 antibodies Feb. 21, 2017
  • Patent Title: Compositions and methods for treating ige-mediated disorders Jan. 10, 2017
  • Patent Title: Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens Nov. 15, 2016
  • Patent Title: Antibody variants with enhanced complement activity Oct. 25, 2016
  • Patent Title: Methods and compositions for inhibiting cd32b expressing cells Jul. 19, 2016
  • Patent Title: Ctla4-ig immunoadhesins Jun. 21, 2016
  • Patent Title: Optimized fc variants and methods for their generation May. 31, 2016
  • Patent Title: Compositions and methods for treating ige-mediated disorders Feb. 23, 2016
  • Patent Title: Methods and compositions for inhibiting cd32b expressing cells Feb. 16, 2016
  • Patent Title: Compositions and methods for treating ige-mediated disorders Dec. 29, 2015
  • Patent Title: Fc variants with altered binding to fcrn Dec. 01, 2015
  • Patent Title: Optimized fc variants and methods for their generation Nov. 24, 2015
  • Patent Title: Methods and compositions for inhibiting cd32b expressing cells Jul. 14, 2015
  • Patent Title: Compositions and methods for treating ige-mediated disorders Jun. 23, 2015
  • Patent Title: Optimized fc variants Jun. 09, 2015
  • Patent Title: Optimized antibodies that target hm1.24 May. 26, 2015
  • Patent Title: Modified fc molecules May. 26, 2015
  • Patent Title: Fc variants with increased affinity for fcγriic Jan. 20, 2015
  • Patent Title: Fc variants with altered binding to fcrn Nov. 11, 2014
  • Patent Title: Immunoglobulins insertions, deletions, and substitutions Nov. 11, 2014
  • Patent Title: Optimized fc variants and methods for their generation Oct. 14, 2014
  • Patent Title: Fc variants with altered binding to fcrn Oct. 07, 2014
  • Patent Title: Optimized fc variants and methods for their generation Aug. 19, 2014
  • Patent Title: Optimized fc variants Aug. 12, 2014
  • Patent Title: Fc variants with altered binding to fcrn Aug. 12, 2014
  • Patent Title: Optimized fc variants Jun. 17, 2014
  • Patent Title: Optimized fc variants Jun. 17, 2014
  • Patent Title: Optimized fc variants May. 27, 2014
  • Patent Title: Fc variants having increased affinity for fcyrllc May. 27, 2014
  • Patent Title: Optimized fc variants and methods for their generation May. 27, 2014
  • Patent Title: Antibodies with modified isoelectric points Jan. 28, 2014
  • Patent Title: Ctla4-ig immunoadhesins Jan. 14, 2014
  • Patent Title: Anti-cd40 antibodies and methods of inhibiting proliferation of cd40 expressing cells Oct. 08, 2013
  • Patent Title: Fc variants that extend antibody half-life Oct. 01, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to XNCR from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
XNCR News

Recent insights relating to XNCR

CNBC Recommendations

Recent picks made for XNCR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in XNCR

XNCR Analyst Ratings

XNCR Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
XNCR Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $XNCR stock a Buy, Sell, or Hold?

  • What is the price target for $XNCR stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

XNCR Top Shareholders
Shareholder
Shares Held
XNCR Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $XNCR stock?

  • Who owns the most shares of $XNCR stock?

  • What funds own $XNCR stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

XNCR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view XNCR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About XNCR

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

  • Address Pasadena, CA
  • Market Cap 1.8 billion
  • Employees 260
  • Industrial Classification Pharmaceutical Preparations

Xencor, Inc. (XNCR) Historical Stock Prices

Xencor, Inc. (XNCR) closed at $23.80 on September 25, 2026. Over the past year its adjusted close ranged from $10.33 to $29.30. Daily prices go back to January 2, 2014, 3,202 trading days in all.

  • 1 month-16.32%
  • 3 months+58.14%
  • Year to date+55.45%
  • 1 year+130.40%
  • 3 years+18.53%
  • 5 years-29.75%
  • Max+168.02%
See every congressional and insider trade on the XNCR price chart

Quiver Premium charts XNCR's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 25, 2026 24.10 24.29 23.30 23.80 23.80 1,169,672
Sep 24, 2026 24.16 24.69 23.69 23.88 23.88 952,643
Sep 23, 2026 25.42 25.63 23.99 24.26 24.26 1,156,610
Sep 22, 2026 25.08 25.70 24.86 25.16 25.16 1,223,604
Sep 21, 2026 25.46 25.46 24.64 25.03 25.03 1,389,706
Sep 18, 2026 24.45 25.02 24.13 24.72 24.72 5,207,447
Sep 17, 2026 24.25 24.86 23.98 24.59 24.59 1,027,007
Sep 16, 2026 23.87 24.11 23.64 23.71 23.71 1,230,466
Sep 15, 2026 24.42 24.42 23.36 23.75 23.75 1,818,841
Sep 14, 2026 24.71 24.95 24.46 24.53 24.53 858,322
Sep 11, 2026 24.72 24.84 23.96 24.41 24.41 905,274
Sep 10, 2026 24.63 24.63 23.86 24.26 24.26 1,360,986
Sep 9, 2026 25.12 26.18 24.85 24.94 24.94 1,178,304
Sep 8, 2026 26.09 26.49 24.93 25.33 25.33 1,237,757
Sep 4, 2026 26.05 26.76 25.40 26.61 26.61 919,792
Sep 3, 2026 27.18 27.23 26.05 26.62 26.62 1,321,480
Sep 2, 2026 28.20 28.98 26.04 26.90 26.90 1,018,293
Sep 1, 2026 27.19 28.08 26.71 27.91 27.91 1,475,981
Aug 31, 2026 26.00 27.64 25.89 27.27 27.27 1,808,116
Aug 28, 2026 28.97 28.97 25.80 26.06 26.06 2,051,639
Aug 27, 2026 28.16 28.94 27.80 28.88 28.88 1,553,695
Aug 26, 2026 28.71 29.23 28.44 28.44 28.44 2,121,833
Aug 25, 2026 29.00 30.61 29.00 29.30 29.30 1,566,748
Aug 24, 2026 27.80 29.42 27.14 29.00 29.00 1,050,750
Aug 21, 2026 27.30 28.16 27.07 27.80 27.80 753,106
Aug 20, 2026 27.01 27.70 26.52 27.00 27.00 1,655,225
Aug 19, 2026 26.03 27.59 25.55 27.52 27.52 2,351,122
Aug 18, 2026 22.81 25.53 22.79 25.41 25.41 1,604,652
Aug 17, 2026 23.21 23.47 22.91 23.12 23.12 962,159
Aug 14, 2026 22.91 23.45 22.50 23.34 23.34 443,070
Aug 13, 2026 23.36 23.40 22.53 22.99 22.99 975,295
Aug 12, 2026 22.13 23.34 21.89 23.18 23.18 1,967,662
Aug 11, 2026 21.75 22.22 21.38 22.10 22.10 1,109,981
Aug 10, 2026 20.91 21.81 20.48 21.58 21.58 1,263,697
Aug 7, 2026 20.22 21.05 19.93 20.81 20.81 1,124,578
Aug 6, 2026 21.96 21.96 19.07 20.00 20.00 996,659
Aug 5, 2026 20.01 20.33 19.65 19.84 19.84 826,085
Aug 4, 2026 19.69 20.26 19.49 19.92 19.92 760,790
Aug 3, 2026 20.07 20.24 19.09 19.40 19.40 714,422
Jul 31, 2026 21.50 21.57 19.77 20.21 20.21 1,318,724
Jul 30, 2026 19.68 21.76 19.66 21.49 21.49 1,615,605
Jul 29, 2026 19.93 20.12 19.20 19.53 19.53 1,161,148
Jul 28, 2026 19.84 20.14 19.04 19.97 19.97 845,863
Jul 27, 2026 19.48 20.60 19.46 19.86 19.86 942,303
Jul 24, 2026 19.53 19.90 18.94 19.44 19.44 632,988
Jul 23, 2026 19.18 20.02 18.84 19.53 19.53 832,624
Jul 22, 2026 20.59 20.64 18.80 19.51 19.51 1,259,672
Jul 21, 2026 18.85 21.26 18.82 20.45 20.45 1,826,707
Jul 20, 2026 17.62 20.26 17.62 18.81 18.81 2,862,466
Jul 17, 2026 14.68 17.68 14.60 17.47 17.47 1,684,195
Jul 16, 2026 14.95 14.96 14.38 14.95 14.95 636,626
Jul 15, 2026 14.87 15.03 14.48 14.98 14.98 487,639
Jul 14, 2026 14.96 15.24 14.60 14.95 14.95 581,678
Jul 13, 2026 15.53 15.53 14.67 14.96 14.96 662,576
Jul 10, 2026 15.84 15.89 15.11 15.85 15.85 544,665
Jul 9, 2026 16.40 16.98 15.78 16.11 16.11 1,478,030
Jul 8, 2026 15.47 16.51 15.36 16.46 16.46 1,164,151
Jul 7, 2026 14.92 15.78 14.72 15.67 15.67 719,118
Jul 6, 2026 14.97 15.20 14.61 14.89 14.89 504,887
Jul 2, 2026 15.39 15.72 14.69 15.00 15.00 919,419
Jul 1, 2026 15.93 16.10 15.36 15.38 15.38 1,020,105
Jun 30, 2026 15.69 16.80 15.46 16.10 16.10 1,500,302
Jun 29, 2026 15.30 15.62 14.82 15.60 15.60 749,505
Jun 26, 2026 14.82 15.57 14.59 15.05 15.05 1,981,661
Jun 25, 2026 14.89 15.31 14.43 14.74 14.74 874,739
Jun 24, 2026 14.28 14.95 14.28 14.45 14.45 825,398
Jun 23, 2026 13.90 14.50 13.90 14.08 14.08 1,142,537
Jun 22, 2026 12.89 14.21 12.89 14.01 14.01 1,203,500
Jun 18, 2026 13.06 13.32 12.49 12.64 12.64 1,815,287
Jun 17, 2026 12.24 13.26 12.24 12.78 12.78 1,051,847
Jun 16, 2026 12.25 12.36 11.90 12.20 12.20 871,478
Jun 15, 2026 12.31 12.60 11.99 12.21 12.21 638,904
Jun 12, 2026 12.34 12.53 12.02 12.33 12.33 591,563
Jun 11, 2026 11.80 12.27 11.56 12.09 12.09 500,334
Jun 10, 2026 11.82 12.24 11.57 11.83 11.83 650,972
Jun 9, 2026 11.61 12.04 11.57 11.89 11.89 1,009,031
Jun 8, 2026 11.90 11.96 11.20 11.41 11.41 776,181
Jun 5, 2026 12.08 12.08 11.55 11.77 11.77 862,565
Jun 4, 2026 11.84 12.12 11.51 12.01 12.01 942,670
Jun 3, 2026 11.30 11.44 11.23 11.42 11.42 602,704
Jun 2, 2026 11.61 11.67 11.07 11.21 11.21 595,388
Jun 1, 2026 11.83 11.99 11.51 11.80 11.80 709,375
May 29, 2026 11.97 12.22 11.75 11.88 11.88 647,066
May 28, 2026 11.70 12.02 11.40 11.97 11.97 374,951
May 27, 2026 11.57 12.14 11.53 11.72 11.72 484,449
May 26, 2026 11.40 11.75 11.28 11.63 11.63 526,296
May 22, 2026 11.29 11.62 11.20 11.31 11.31 522,183
May 21, 2026 11.10 11.46 11.01 11.27 11.27 642,663
May 20, 2026 10.49 11.38 10.49 11.32 11.32 905,041
May 19, 2026 10.99 10.99 10.38 10.41 10.41 794,258
May 18, 2026 11.03 11.40 10.86 11.06 11.06 854,126
May 15, 2026 11.66 11.66 10.97 11.22 11.22 895,182
May 14, 2026 12.32 12.35 11.77 11.88 11.88 570,374
May 13, 2026 12.36 12.47 12.00 12.38 12.38 761,921
May 12, 2026 12.84 13.00 12.40 12.44 12.44 664,326
May 11, 2026 13.01 13.49 12.75 12.79 12.79 857,049
May 8, 2026 12.22 13.15 12.00 12.86 12.86 899,514
May 7, 2026 12.64 13.21 12.10 12.31 12.31 947,693
May 6, 2026 12.93 13.22 12.72 13.01 13.01 819,660
May 5, 2026 13.49 13.82 12.51 12.85 12.85 697,431
May 4, 2026 12.81 13.46 12.80 13.36 13.36 1,297,674
May 1, 2026 11.89 12.93 11.81 12.69 12.69 869,538
Apr 30, 2026 11.70 12.04 11.60 11.93 11.93 460,254
Apr 29, 2026 11.88 11.97 11.47 11.62 11.62 903,080
Apr 28, 2026 13.05 13.35 11.89 12.15 12.15 1,045,210
Apr 27, 2026 12.86 13.56 12.86 13.10 13.10 1,115,832
Apr 24, 2026 12.43 13.24 12.21 12.98 12.98 627,251
Apr 23, 2026 12.84 13.05 12.33 12.45 12.45 335,047
Apr 22, 2026 12.69 13.01 12.51 12.85 12.85 630,953
Apr 21, 2026 12.78 12.78 12.46 12.61 12.61 395,775
Apr 20, 2026 13.11 13.40 12.78 12.80 12.80 643,723
Apr 17, 2026 12.79 13.16 12.74 13.06 13.06 877,135
Apr 16, 2026 12.54 12.61 12.00 12.45 12.45 635,514
Apr 15, 2026 12.65 12.82 12.25 12.51 12.51 978,365
Apr 14, 2026 12.07 12.65 12.04 12.51 12.51 806,981
Apr 13, 2026 12.53 13.30 12.04 12.07 12.07 771,736
Apr 10, 2026 12.61 12.61 12.18 12.42 12.42 530,508
Apr 9, 2026 12.15 12.59 12.05 12.53 12.53 1,013,458
Apr 8, 2026 12.97 13.20 11.99 12.25 12.25 974,756
Apr 7, 2026 12.60 12.60 11.98 12.31 12.31 490,005
Apr 6, 2026 12.79 13.10 12.38 12.44 12.44 864,662
Apr 2, 2026 12.21 12.82 12.20 12.81 12.81 608,555
Apr 1, 2026 12.35 12.73 12.17 12.53 12.53 1,030,547
Mar 31, 2026 11.51 12.44 11.17 12.06 12.06 1,090,535
Mar 30, 2026 11.46 11.61 10.96 11.35 11.35 938,643
Mar 27, 2026 12.17 12.40 11.27 11.42 11.42 845,999
Mar 26, 2026 12.01 12.82 12.01 12.31 12.31 811,310
Mar 25, 2026 12.10 12.79 11.96 12.40 12.40 638,277
Mar 24, 2026 11.37 12.01 11.04 11.89 11.89 1,275,249
Mar 23, 2026 12.21 12.50 11.98 12.05 12.05 1,516,696
Mar 20, 2026 12.17 12.41 11.79 12.13 12.13 2,315,328
Mar 19, 2026 11.45 12.30 11.34 12.12 12.12 852,418
Mar 18, 2026 11.75 11.75 11.37 11.59 11.59 746,634
Mar 17, 2026 12.05 12.25 11.68 11.74 11.74 800,976
Mar 16, 2026 11.75 12.50 11.75 12.03 12.03 759,327
Mar 13, 2026 11.72 12.08 11.45 12.00 12.00 646,477
Mar 12, 2026 11.72 11.74 11.22 11.61 11.61 1,137,841
Mar 11, 2026 11.82 12.13 11.55 12.04 12.04 745,263
Mar 10, 2026 11.95 12.36 11.62 11.98 11.98 931,931
Mar 9, 2026 11.25 12.00 11.24 11.87 11.87 835,917
Mar 6, 2026 10.85 11.32 10.62 11.32 11.32 877,476
Mar 5, 2026 11.85 11.98 10.89 11.16 11.16 1,649,549
Mar 4, 2026 12.25 12.80 11.85 12.74 12.74 705,800
Mar 3, 2026 11.92 12.24 11.48 12.02 12.02 788,913
Mar 2, 2026 12.37 13.30 11.85 12.30 12.30 848,719
Feb 27, 2026 13.49 13.57 12.67 12.77 12.77 874,816
Feb 26, 2026 12.43 14.54 12.06 13.55 13.55 1,511,309
Feb 25, 2026 12.10 12.35 11.83 11.98 11.98 712,468
Feb 24, 2026 11.84 12.19 11.59 11.81 11.81 484,355
Feb 23, 2026 11.39 11.79 11.23 11.57 11.57 547,165
Feb 20, 2026 11.80 11.81 11.14 11.41 11.41 487,483
Feb 19, 2026 11.24 11.90 11.12 11.74 11.74 666,483
Feb 18, 2026 11.45 11.70 11.19 11.34 11.34 395,999
Feb 17, 2026 11.54 11.73 11.17 11.54 11.54 580,691
Feb 13, 2026 11.76 11.95 11.36 11.59 11.59 417,284
Feb 12, 2026 12.26 12.55 11.25 11.62 11.62 414,975
Feb 11, 2026 12.36 12.59 11.75 12.22 12.22 415,474
Feb 10, 2026 11.98 12.73 11.95 12.37 12.37 680,785
Feb 9, 2026 11.57 12.06 11.30 11.93 11.93 407,500
Feb 6, 2026 11.14 11.65 11.01 11.61 11.61 630,096
Feb 5, 2026 11.36 11.87 10.76 10.82 10.82 487,644
Feb 4, 2026 12.05 12.13 11.38 11.53 11.53 466,326
Feb 3, 2026 12.11 12.44 11.76 11.99 11.99 471,276
Feb 2, 2026 12.00 12.42 11.85 12.11 12.11 584,951
Jan 30, 2026 12.55 12.72 11.82 12.09 12.09 565,401
Jan 29, 2026 12.33 12.79 12.33 12.38 12.38 406,320
Jan 28, 2026 13.22 13.38 12.28 12.35 12.35 635,120
Jan 27, 2026 13.02 13.63 12.93 13.17 13.17 352,554
Jan 26, 2026 12.62 13.08 12.50 13.02 13.02 641,201
Jan 23, 2026 13.03 13.22 12.51 12.78 12.78 616,797
Jan 22, 2026 12.94 13.74 12.93 13.11 13.11 735,058
Jan 21, 2026 12.62 13.10 12.61 13.00 13.00 678,999
Jan 20, 2026 12.50 12.78 12.41 12.64 12.64 869,698
Jan 16, 2026 13.53 13.65 12.76 12.79 12.79 673,540
Jan 15, 2026 14.42 14.65 13.19 13.21 13.21 514,903
Jan 14, 2026 13.85 14.65 13.71 14.45 14.45 560,216
Jan 13, 2026 14.21 14.24 13.77 13.94 13.94 517,045
Jan 12, 2026 13.89 14.38 13.80 14.17 14.17 930,925
Jan 9, 2026 14.22 14.50 13.81 13.89 13.89 1,397,179
Jan 8, 2026 14.39 14.66 13.94 14.19 14.19 931,738
Jan 7, 2026 14.08 15.40 13.99 14.95 14.95 1,595,904
Jan 6, 2026 14.14 14.48 13.77 14.06 14.06 1,109,903
Jan 5, 2026 14.99 15.09 13.83 14.27 14.27 723,447
Jan 2, 2026 15.31 15.36 14.71 14.92 14.92 603,192
Dec 31, 2025 15.03 15.42 14.85 15.31 15.31 485,728
Dec 30, 2025 15.11 15.21 14.90 15.03 15.03 380,258
Dec 29, 2025 15.08 15.41 14.93 15.17 15.17 438,904
Dec 26, 2025 15.45 15.45 15.05 15.22 15.22 421,713
Dec 24, 2025 15.21 15.50 14.97 15.45 15.45 278,044
Dec 23, 2025 15.74 16.04 15.22 15.47 15.47 546,910
Dec 22, 2025 15.49 16.17 15.30 15.97 15.97 583,139
Dec 19, 2025 15.70 16.11 15.51 15.55 15.55 2,847,652
Dec 18, 2025 15.83 16.31 15.53 15.69 15.69 595,189
Dec 17, 2025 16.50 16.89 15.62 15.80 15.80 681,066
Dec 16, 2025 16.59 16.92 16.45 16.55 16.55 1,037,989
Dec 15, 2025 16.71 17.18 16.45 16.79 16.79 872,861
Dec 12, 2025 17.02 17.14 16.43 16.52 16.52 507,467
Dec 11, 2025 16.99 17.62 16.94 17.06 17.06 611,379
Dec 10, 2025 16.80 17.33 16.58 17.16 17.16 610,991
Dec 9, 2025 17.58 17.98 16.70 16.81 16.81 1,684,897
Dec 8, 2025 17.75 18.30 17.44 17.68 17.68 699,934
Dec 5, 2025 18.40 18.69 17.27 17.30 17.30 552,847
Dec 4, 2025 17.50 18.68 17.02 18.14 18.14 951,185
Dec 3, 2025 16.03 17.33 16.03 17.31 17.31 528,193
Dec 2, 2025 16.56 16.71 15.69 15.99 15.99 575,735
Dec 1, 2025 17.00 17.00 16.41 16.51 16.51 496,851
Nov 28, 2025 17.53 17.83 17.20 17.32 17.32 214,164
Nov 26, 2025 17.36 17.80 17.14 17.38 17.38 1,231,220
Nov 25, 2025 16.94 17.55 16.78 17.26 17.26 813,210
Nov 24, 2025 16.15 17.07 16.01 16.74 16.74 698,592
Nov 21, 2025 15.61 16.21 15.38 15.87 15.87 628,229
Nov 20, 2025 15.99 16.63 15.42 15.57 15.57 549,751
Nov 19, 2025 16.02 16.24 15.66 15.77 15.77 666,205
Nov 18, 2025 15.62 16.55 15.39 16.02 16.02 1,284,991
Nov 17, 2025 14.90 16.00 14.72 15.62 15.62 990,283
Nov 14, 2025 13.83 15.09 13.73 14.93 14.93 788,523
Nov 13, 2025 14.19 14.42 13.77 13.99 13.99 662,730
Nov 12, 2025 14.78 15.29 14.36 14.39 14.39 919,097
Nov 11, 2025 14.02 15.02 13.75 14.87 14.87 601,796
Nov 10, 2025 14.34 14.34 13.57 13.74 13.74 959,420
Nov 7, 2025 13.75 13.94 13.12 13.90 13.90 897,740
Nov 6, 2025 14.40 15.16 13.83 14.00 14.00 1,060,735
Nov 5, 2025 13.70 14.40 13.39 14.37 14.37 944,341
Nov 4, 2025 13.55 14.46 13.30 13.70 13.70 1,071,680
Nov 3, 2025 14.49 14.76 13.43 13.94 13.94 1,026,212
Oct 31, 2025 14.13 14.85 13.80 14.71 14.71 1,210,912
Oct 30, 2025 14.44 14.88 14.06 14.13 14.13 962,561
Oct 29, 2025 15.24 15.50 14.47 14.67 14.67 1,748,993
Oct 28, 2025 14.10 14.66 14.01 14.25 14.25 1,219,533
Oct 27, 2025 13.72 14.83 13.50 14.27 14.27 1,636,943
Oct 24, 2025 12.47 14.20 12.30 13.21 13.21 1,563,387
Oct 23, 2025 13.25 13.29 12.16 12.34 12.34 1,290,453
Oct 22, 2025 14.51 14.59 13.27 13.29 13.29 1,892,038
Oct 21, 2025 15.07 15.34 14.28 14.51 14.51 1,155,656
Oct 20, 2025 14.94 15.69 14.60 15.07 15.07 2,007,764
Oct 17, 2025 14.85 15.07 14.47 14.77 14.77 1,938,298
Oct 16, 2025 14.40 15.37 14.38 14.95 14.95 3,193,232
Oct 15, 2025 12.58 14.25 12.47 14.10 14.10 1,414,312
Oct 14, 2025 13.95 13.98 11.17 12.43 12.43 2,898,409
Oct 13, 2025 13.13 13.99 13.02 13.96 13.96 1,052,962
Oct 10, 2025 13.12 13.12 12.42 13.03 13.03 699,535
Oct 9, 2025 12.44 13.14 12.13 13.06 13.06 1,603,025
Oct 8, 2025 12.14 12.61 11.94 12.40 12.40 960,600
Oct 7, 2025 11.84 12.09 11.36 12.03 12.03 959,637
Oct 6, 2025 12.06 12.63 11.78 11.79 11.79 927,188
Oct 3, 2025 11.94 12.12 11.72 11.77 11.77 540,911
Oct 2, 2025 11.91 12.02 11.67 11.82 11.82 982,391
Oct 1, 2025 11.64 12.00 11.54 11.83 11.83 851,703
Sep 30, 2025 11.51 11.88 11.30 11.73 11.73 1,237,996
Sep 29, 2025 11.59 11.81 11.20 11.55 11.55 1,123,776
Sep 26, 2025 10.46 11.71 10.39 11.57 11.57 1,055,688
Sep 25, 2025 10.36 10.48 10.24 10.33 10.33 428,710

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Xencor, Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at XNCR, per a recent SEC DEF 14A filing. We estimate that the median employee at Xencor Inc is paid $270,292.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation